Fundsmith Emerging Equities Trust (FEET)

Last close As at 21/05/2024

1,240.00

0.00 (0.00%)

Market capitalisation

GBP326m

Edison Investment Research is terminating coverage on Fundsmith Emerging Equities Trust. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

 

Previously published reports can still be accessed via our website.

Latest Insights

Investment Companies | Review

Fundsmith Emerging Equities Trust — Stepping forward

Investment Companies | edison tv

The risks of investing in China

Investment Companies | Initiation

Fundsmith Emerging Equities Trust — Sticking to its guns

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (6.4) 5.5 (13.6)
Relative (12.5) 8.0 (10.8)
52 week high/low 1460.0p/1055.0p

Overview

Fundsmith Emerging Equities Trust’s investment objective is to provide shareholders with an attractive return by investing in a portfolio of listed companies that operate in or sell into developing economies, providing exposure to the growing proportion of middle-class consumers in these countries or to the broader social and/or economic development of those countries.

Research

thematic

Investment Companies

Vietnamese equities: Due a comeback?

thematic

Investment Companies

Investment companies: Latin America is worthy of consideration

thematic

Consumer

IPO apocalypse

thematic

TMT

ESG, moving beyond the box tick

thematic

Investment Companies

The case for US capital markets

thematic

Investment Companies

Value Investing: Living with the reality, waiting for the inevitable

thematic

Consumer

Illuminator: August Update

thematic

Investment Companies

Post Woodford- A spotlight on smaller company liquidity

thematic

Investment Companies

How to buy and sell investment trusts

thematic

Investment Companies

Types of investment trusts

thematic

Consumer

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Investment Companies

Investment Trusts Quarterly: Biotechnology & healthcare trusts

thematic

Investment Companies

Investment Trusts Quarterly: Growth and income